Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Liddle

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Plos One|February 18, 2014
Binding sites analyser (BiSA): software for genomic binding sites archiving and overlap analysisMatloob Khushi, Christopher Liddle, Christine L Clarke, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2008
Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosingMarina Kacevska, Graham R Robertson, Stephen J Clarke, et al.
Kidney International|December 1, 2005
Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathyJason D Coombes, Ellein Mreich, Christopher Liddle, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2009
Hepatobiliary ABC transporters: physiology, regulation and implications for diseaseJohan W Jonker, Catherine A M Stedman, Christopher Liddle, et al.
Molecular Pharmacology|July 20, 2002
Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptorBryan Goodwin, Ecushla Hodgson, Daniel J D'Costa, et al.
Journal of Inflammation Research|April 9, 2021
Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 PathogenesisScott A Read, Brian S Gloss, Christopher Liddle, et al.
Cancer Letters|April 20, 2016
Overcoming treatment resistance in cancer: Current understanding and tacticsGuang Wu, George Wilson, Jacob George, et al.
Clinical Colorectal Cancer|September 17, 2008
Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancerRohini Sharma, Manuela Zucknick, Roslyn London, et al.
Plos One|March 27, 2015
Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injuryChristopher Scott, Kuan Cha, Renuka Rao, et al.
Oncotarget|February 11, 2016
Aptamers: A promising chemical antibody for cancer therapyGang Zhou, George Wilson, Lionel Hebbard, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Plos One|February 18, 2014
Binding sites analyser (BiSA): software for genomic binding sites archiving and overlap analysisMatloob Khushi, Christopher Liddle, Christine L Clarke, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2008
Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosingMarina Kacevska, Graham R Robertson, Stephen J Clarke, et al.
Kidney International|December 1, 2005
Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathyJason D Coombes, Ellein Mreich, Christopher Liddle, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2009
Hepatobiliary ABC transporters: physiology, regulation and implications for diseaseJohan W Jonker, Catherine A M Stedman, Christopher Liddle, et al.
Molecular Pharmacology|July 20, 2002
Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptorBryan Goodwin, Ecushla Hodgson, Daniel J D'Costa, et al.
Journal of Inflammation Research|April 9, 2021
Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 PathogenesisScott A Read, Brian S Gloss, Christopher Liddle, et al.
Cancer Letters|April 20, 2016
Overcoming treatment resistance in cancer: Current understanding and tacticsGuang Wu, George Wilson, Jacob George, et al.
Clinical Colorectal Cancer|September 17, 2008
Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancerRohini Sharma, Manuela Zucknick, Roslyn London, et al.
Plos One|March 27, 2015
Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injuryChristopher Scott, Kuan Cha, Renuka Rao, et al.
Oncotarget|February 11, 2016
Aptamers: A promising chemical antibody for cancer therapyGang Zhou, George Wilson, Lionel Hebbard, et al.
Pageof 14